Copart, Inc. (LON:0ACI)
London · Delayed Price · Currency is GBP · Price in USD 45.17
-1.20 (-2.58%)
At close: Aug 1, 2025
Intra-Cellular Therapies Market Cap
Copart has a market cap or net worth of 33.22 billion as of August 1, 2025. Its market cap has decreased by -15.27% in one year.
Market Cap
33.22B
Enterprise Value
30.00B
Revenue
3.44B
Ranking
n/a
PE Ratio
29.96
Stock Price
$45.17
Market Cap Chart
Since March 17, 1994, Copart's market cap has increased from 82.30M to 33.22B, an increase of 40,267.31%. That is a compound annual growth rate of 21.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 33.22B | -24.79% |
| Dec 31, 2024 | 44.17B | 19.57% |
| Dec 29, 2023 | 36.94B | 53.46% |
| Dec 30, 2022 | 24.07B | -9.37% |
| Dec 31, 2021 | 26.56B | 20.68% |
| Dec 31, 2020 | 22.01B | 37.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.60B |
| Shell | 159.31B |
| HSBC Holdings | 159.21B |
| Unilever | 109.82B |
| Rolls-Royce Holdings | 89.59B |
| British American Tobacco p.l.c. | 88.30B |
| Rio Tinto Group | 76.37B |
| RELX PLC | 71.14B |